390 related articles for article (PubMed ID: 31183805)
21. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study.
Kelly CM; van Oosterhout JJ; Ngwalo C; Stewart RC; Benjamin L; Robertson KR; Khoo S; Allain TJ; Solomon T
PLoS One; 2014; 9(6):e98962. PubMed ID: 24915530
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D insufficiency is associated with subclinical atherosclerosis in HIV-1-infected patients on combination antiretroviral therapy.
Calza L; Borderi M; Granozzi B; Malosso P; Pancaldi L; Bon I; Re MC
HIV Res Clin Pract; 2019 Dec; 20(6):131-139. PubMed ID: 32065065
[No Abstract] [Full Text] [Related]
23. Liver-related factors associated with low vitamin D levels in HIV and HIV/HCV coinfected patients and comparison to general population.
Milazzo L; Mazzali C; Bestetti G; Longhi E; Foschi A; Viola A; Vago T; Galli M; Parravicini C; Antinori S
Curr HIV Res; 2011 Apr; 9(3):186-93. PubMed ID: 21585333
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D deficiency and insufficiency in HIV-infected children and young adults.
Meyzer C; Frange P; Chappuy H; Desse B; Veber F; Le Clésiau H; Friedlander G; Blanche S; Souberbielle JC; Tréluyer JM; Courbebaisse M
Pediatr Infect Dis J; 2013 Nov; 32(11):1240-4. PubMed ID: 23907260
[TBL] [Abstract][Full Text] [Related]
25. High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs.
Allavena C; Delpierre C; Cuzin L; Rey D; Viget N; Bernard J; Guillot P; Duvivier C; Billaud E; Raffi F
J Antimicrob Chemother; 2012 Sep; 67(9):2222-30. PubMed ID: 22589455
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and 1-year incidence of HIV-associated neurocognitive disorder (HAND) in adults aged ≥50 years attending standard HIV clinical care in Kilimanjaro, Tanzania.
Flatt A; Gentry T; Kellett-Wright J; Eaton P; Joseph M; Urasa S; Howlett W; Dekker M; Kisoli A; Rogathe J; Henderson L; Lewis T; Thornton J; McCartney J; Yarwood V; Irwin C; Mukaetova-Ladinska EB; Akinyemi R; Gray WK; Walker RW; Dotchin CL; Quaker AS; Makupa PC; Paddick SM
Int Psychogeriatr; 2023 Jul; 35(7):339-350. PubMed ID: 33757616
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of vitamin D deficiency among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy.
Chokephaibulkit K; Saksawad R; Bunupuradah T; Rungmaitree S; Phongsamart W; Lapphra K; Maleesatharn A; Puthanakit T
Pediatr Infect Dis J; 2013 Nov; 32(11):1237-9. PubMed ID: 24145954
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D Deficiency and Metabolism in HIV-Infected and HIV-Uninfected Men in the Multicenter AIDS Cohort Study.
Zhang L; Tin A; Brown TT; Margolick JB; Witt MD; Palella FJ; Kingsley LA; Hoofnagle AN; Jacobson LP; Abraham AG
AIDS Res Hum Retroviruses; 2017 Mar; 33(3):261-270. PubMed ID: 27700140
[TBL] [Abstract][Full Text] [Related]
30. Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapy.
Montoya JL; Iudicello J; Oppenheim HA; Fazeli PL; Potter M; Ma Q; Mills PJ; Ellis RJ; Grant I; Letendre SL; Moore DJ;
AIDS; 2017 Mar; 31(6):787-795. PubMed ID: 28099190
[TBL] [Abstract][Full Text] [Related]
31. Depression and diagnosis of neurocognitive impairment in HIV-positive patients.
Pinheiro CA; Souza LD; Motta JV; Kelbert EF; Souza MS; Martins CS; Coelho FM; Pinheiro KA; Pinheiro RT
Braz J Med Biol Res; 2016 Sep; 49(10):e5344. PubMed ID: 27626305
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of vitamin D deficiency in HIV-positive, antiretroviral treatment-naïve patients in a single centre study.
Gedela K; Edwards SG; Benn P; Grant AD
Int J STD AIDS; 2014 Jun; 25(7):488-92. PubMed ID: 24352123
[TBL] [Abstract][Full Text] [Related]
33. Vitamin D deficiency in HIV infection: an underestimated and undertreated epidemic.
Pinzone MR; Di Rosa M; Malaguarnera M; Madeddu G; Focà E; Ceccarelli G; d'Ettorre G; Vullo V; Fisichella R; Cacopardo B; Nunnari G
Eur Rev Med Pharmacol Sci; 2013 May; 17(9):1218-32. PubMed ID: 23690192
[TBL] [Abstract][Full Text] [Related]
34. Risk Factors of Hypovitaminosis D in HIV-Infected Patients on Suppressive Antiretroviral Therapy.
Mikuła T; Sapuła M; Suchacz MM; Kozłowska J; Krankowska D; Stańczak W; Wiercińska-Drapało A
AIDS Res Hum Retroviruses; 2020 Aug; 36(8):676-680. PubMed ID: 32408752
[TBL] [Abstract][Full Text] [Related]
35. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
[TBL] [Abstract][Full Text] [Related]
36. Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection.
Evering TH; Applebaum A; La Mar M; Garmon D; Dorfman D; Markowitz M
AIDS; 2016 Jan; 30(2):203-10. PubMed ID: 26684817
[TBL] [Abstract][Full Text] [Related]
37. Peripheral Blood Mitochondrial DNA Copy Number Obtained From Genome-Wide Genotype Data Is Associated With Neurocognitive Impairment in Persons With Chronic HIV Infection.
Hulgan T; Kallianpur AR; Guo Y; Barnholtz-Sloan JS; Gittleman H; Brown TT; Ellis R; Letendre S; Heaton RK; Samuels DC;
J Acquir Immune Defic Syndr; 2019 Apr; 80(4):e95-e102. PubMed ID: 30531306
[TBL] [Abstract][Full Text] [Related]
38. High 25-hydroxyvitamin D is associated with unexpectedly high plasma inflammatory markers in HIV patients on antiretroviral therapy.
Gangcuangco LMA; Kohorn LB; Chow DC; Keating SM; Norris PJ; Nagamine LS; Ndhlovu LC; Souza SA; Kallianpur KJ; Shikuma CM
Medicine (Baltimore); 2016 Oct; 95(43):e5270. PubMed ID: 27787390
[TBL] [Abstract][Full Text] [Related]
39. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.
Kallianpur AR; Wang Q; Jia P; Hulgan T; Zhao Z; Letendre SL; Ellis RJ; Heaton RK; Franklin DR; Barnholtz-Sloan J; Collier AC; Marra CM; Clifford DB; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Grant I;
J Infect Dis; 2016 Apr; 213(7):1065-73. PubMed ID: 26690344
[TBL] [Abstract][Full Text] [Related]
40. Associations of antiretroviral therapy and comorbidities with neurocognitive outcomes in HIV-1-infected patients.
Siangphoe U; Archer KJ; Nguyen C; Lee KR
AIDS; 2020 May; 34(6):893-902. PubMed ID: 32028325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
